Prostate Cancer: What Every Man (and the People Who Love Him) Should Know

Know Your Prostate — and Your Risk

The prostate is a small, walnut-sized gland that sits below the bladder and wraps around the urethra (the tube urine flows through). It helps make the fluid that protects sperm. Because of where it sits, both the gland itself and its treatments can affect urination and sexual function — which is why we take decisions about it so seriously.

‍

A few things raise the odds of developing prostate cancer:

‍

• Age. Risk climbs steadily after age 50, and most diagnoses happen in men in their 60s and beyond.
• Race. Black men are diagnosed more often, tend to be diagnosed younger, and face worse outcomes — an important reason this group benefits from starting the conversation earlier (more on this below).
• Family history. A father or brother with prostate cancer roughly doubles your risk, and the risk rises further with multiple relatives.
• Genetics. Certain inherited gene changes — especially BRCA2, and others linked to breast, ovarian, and colon cancers — can raise risk and sometimes change how aggressive a cancer behaves.

‍

Knowing where you fall helps us decide when and whether screening makes sense for you. It's a personal calculation, not a one-size-fits-all rule.

‍

PSA Screening: A Conversation Worth Having

Screening usually starts with a simple blood test called PSA (prostate-specific antigen). A higher-than-expected PSA can be an early signal of prostate cancer — but it can also rise for completely harmless reasons, like an enlarged prostate, recent activity, or infection. That's the catch with PSA: it's useful, but it isn't a yes-or-no cancer test.

‍

Because of that, the major medical groups don't all give identical advice on exactly when to start. What they agree on, though, is the most important thing: screening should be a shared decision between you and your clinician — weighing the benefit of catching a dangerous cancer early against the downsides, like anxiety and extra testing. In general, the conversation begins around age 50 for men at average risk, and earlier (around 40 to 45) for those at higher risk.

‍

The good news is that modern medicine has gotten much smarter about reducing the downsides. The biggest shift in recent years: when a PSA is concerning, the next step is now usually an MRI scan before any biopsy — not an automatic biopsy. This helps us see whether there's actually a suspicious area, often sparing men an unnecessary procedure.

‍

If Your PSA Is Elevated: The Modern Path Forward

First, take a breath. An elevated PSA does not mean you have cancer. Most men with a high PSA turn out not to have a dangerous cancer at all. Today's approach is careful and stepwise, designed to avoid both missing serious disease and overreacting to harmless findings. In broad strokes, it looks like this:

‍

1. Confirm and contextualize the PSA — repeating it, accounting for things that can falsely raise it.
2. Consider a smarter blood or urine test — beyond plain PSA, validated tests like the 4Kscore, PHI, PCA3, and ExoDx can refine your risk and help decide whether a biopsy is truly needed.
3. Get an MRI of the prostate — radiologists score suspicious areas on a scale called PI-RADS (1 = very unlikely cancer, 5 = highly suspicious).
4. Biopsy only the areas that matter — using MRI-fusion targeted biopsy, which overlays the MRI images onto live ultrasound so the doctor can sample the exact suspicious spot, not just random areas.
5. Use the transperineal approach when possible — taking the biopsy through the skin behind the scrotum rather than through the rectum, which has been shown to lower infection risk.
6. Review everything together — combining your PSA trend, biomarkers, MRI, and biopsy to make a clear, personalized plan.

‍

This careful, step-by-step approach is designed to find every cancer that needs attention while sparing men from unnecessary procedures and treatment they don't need — the best of both worlds.

‍

Treatment Options, Matched to Your Risk

If a cancer is found, there is rarely just one "right" answer. The best choice depends on your risk level, your age and health, and what matters most to you. Here are the main paths, in brief:

‍

• Active surveillance — for many men with low-risk cancer, closely monitoring rather than treating right away is the safest choice, with treatment reserved for if things change.
• Surgery — removing the prostate, often with robotic, nerve-sparing techniques.
• Radiation therapy — delivered in several effective forms, including external beam and implanted sources (brachytherapy).
• Focal therapy — newer, targeted treatments for selected cases.

‍

A Word to Black Men and Their Families

We want to mention something worth knowing: on average, Black men are more likely to be diagnosed with prostate cancer, and to face more serious forms of it. The encouraging part is how much of a difference early attention can make. Because of this, most guidelines suggest that Black men start the screening conversation a little earlier — around age 40 to 45 — especially with any family history.

‍

If this describes you or someone you love, there's no need to worry — just a good reason to start the conversation sooner rather than later. That kind of personalized, unhurried care is exactly what a Direct Primary Care relationship is built for.

‍

Building Your Care Team

Modern prostate cancer care is a team sport. Depending on your situation, that team may include a urologist (often your first specialist), a urologic oncologist for complex cancers, a radiation oncologist, a medical oncologist for systemic therapy, a radiologist skilled in prostate MRI, and nuclear medicine specialists who deliver advanced imaging and targeted treatments.

‍

As your primary care home, our role at Hometown Health DPC is to be your guide and advocate through all of it — helping you decide about screening, interpreting results, coordinating referrals, and making sure your questions get answered without a rushed clock.

‍

The Bottom Line

Prostate cancer is common, but for most men it is highly manageable — and the tools to find it early and treat it well keep getting better. The single most valuable step is a thoughtful, unhurried conversation about whether and when screening is right for you.

‍

That's a conversation we'd love to have. Reach out to Hometown Health DPC to talk through your personal risk and build a plan that fits your life.

‍

‍

This article is for general education and is not a substitute for personalized medical advice. Screening and treatment decisions should always be made with your own clinician, based on your individual health, risk factors, and preferences.

‍

References & Resources

The guidance in this article reflects recommendations from the American Urological Association (AUA), the U.S. Preventive Services Task Force (USPSTF), the European Association of Urology (EAU), the National Comprehensive Cancer Network (NCCN), and the American Cancer Society (ACS), along with major clinical trials including ProtecT, VISION, PROfound, CHAARTED, and STAMPEDE.

‍

For reliable, plain-language patient information, we recommend:

‍

• Prostate Cancer Foundation
• ZERO Prostate Cancer
• American Cancer Society
• Us TOO and other prostate cancer support communities

‍